On Monday, Zai Lab Limited ADR (NASDAQ: ZLAB) was -4.75% drop from the session before settling in for the closing price of $36.42. A 52-week range for ZLAB has been $13.48 – $37.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 118.89% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 40.48%. With a float of $108.11 million, this company’s outstanding shares have now reached $109.14 million.
In an organization with 1869 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 62.94%, operating margin of -70.71%, and the pretax margin is -64.44%.
Zai Lab Limited ADR (ZLAB) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zai Lab Limited ADR stocks. The insider ownership of Zai Lab Limited ADR is 0.95%, while institutional ownership is 51.30%. The most recent insider transaction that took place on Mar 05 ’25, was worth 1,649,122. Before that another transaction happened on Mar 05 ’25, when Company’s Director proposed sale 2,500 for $35.07, making the entire transaction worth $87,675.
Zai Lab Limited ADR (ZLAB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.48% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
You can see what Zai Lab Limited ADR (ZLAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach 0.28 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Let’s dig in a bit further. During the last 5-days, its volume was 1.29 million. That was better than the volume of 0.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.58%. Additionally, its Average True Range was 1.99.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 76.71%, which indicates a significant increase from 55.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.29% in the past 14 days, which was higher than the 56.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.65, while its 200-day Moving Average is $23.97. However, in the short run, Zai Lab Limited ADR’s stock first resistance to watch stands at $35.76. Second resistance stands at $36.84. The third major resistance level sits at $37.56. If the price goes on to break the first support level at $33.97, it is likely to go to the next support level at $33.25. Assuming the price breaks the second support level, the third support level stands at $32.17.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
There are 109,428K outstanding shares of the company, which has a market capitalization of 3.79 billion. As of now, sales total 398,990 K while income totals -257,100 K. Its latest quarter income was 109,070 K while its last quarter net income were -81,680 K.
